Albireo’s Bylvay approved in EU and US for rare paediatric liver disease by Lucy Parsons | Jul 22, 2021 | News | 0 PFIC is a rare and progressive liver disease affecting young children which can lead to cirrhosis and liver failure Read More
Albireo submits rare liver disease med odevixibat to FDA and EMA by Lucy Parsons | Dec 11, 2020 | News | 0 If approved, drug will become first treatment for PFIC patients in the US and EU Read More